Noninvasive monitoring in a patient with SAH diagnosis treated with Cerebrolysin - case report and review of the literature

Eur Rev Med Pharmacol Sci. 2023 Jul;27(14):6843-6849. doi: 10.26355/eurrev_202307_33155.

Abstract

Background: Subarachnoid hemorrhage (SAH) causes a high percentage of deaths and rehabilitation failures. Despite endovascular and surgery treatment algorithms, there is still no consensus on the guidelines for monitoring and neuroprotective treatment of patients.

Case report: We report a case of a patient with SAH treated endovascularly. The patient was hospitalized in the intensive care unit and monitored using Near Infrared Spectroscopy (NIRS) and Optic Nerve Diameters Assessment (ONDS).

Conclusions: Early and high-dose Cerebrolysin was used safely as neuroprotective treatment intravenously. The treatment using Cerebrolysin and additional monitoring was beneficial for the patient.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Amino Acids
  • Humans
  • Neuroprotection
  • Spectroscopy, Near-Infrared
  • Subarachnoid Hemorrhage* / diagnostic imaging
  • Subarachnoid Hemorrhage* / drug therapy

Substances

  • cerebrolysin
  • Amino Acids